Effectiveness for adding or switching from other incretin‐related drugs to oral semaglutide in type 2 diabetes
Oral semaglutide reduced HbA1c levels and BW after adding or switching from other incretin-related drugs in Japanese participants with type 2 diabetes.
Authors
- Junko Oya (ORCID: https://orcid.org/0000-0002-6413-2606)
- Ryo Kubota (ORCID: https://orcid.org/0000-0003-1993-7111)
- Tomoko Nakagami (ORCID: https://orcid.org/0000-0003-4376-7212)
- Rika Suda (ORCID: https://orcid.org/0000-0002-7835-9510)
- Mika Shimizu
Institutions
- Tokyo Women's Medical University (JP)
Publication Details
- Journal
- Journal of Diabetes Investigation
- Published
- 2024-12-20
- DOI
- https://doi.org/10.1111/jdi.14391
- Primary Topic
- Diabetes Treatment and Management
- Type
- article
- Field-Weighted Citation Impact
- 0.00